A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIV
- Status
- TERMINATED
- Phase
- PHASE4
Clinical Trials Related to Tuberculosis
Related studies linked through entity extraction aliases.
Lipoarabinomannan (LAM) Enzyme-Linked Immunosorbent Assay (ELISA) in Diagnostics of Childhood Tuberculosis (TB)
- Status
- UNKNOWN
- Phase
- N/A
Pulmonary Tuberculosis and Vitamin D
- Status
- UNKNOWN
- Phase
- PHASE3
Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO)
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Quantiferon-TB Gold in the Assessment of Latent TB in Patients Candidate to Treatment or Treated With TNFα Antagonists
- Status
- UNKNOWN
- Phase
- NA
Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis
- Status
- UNKNOWN
- Phase
- PHASE2
Innovative Approaches to Tuberculosis Control
- Status
- COMPLETED
- Phase
- N/A
A Study of 2 Doses of a New TB Vaccine, MVA85A, in Healthy Volunteers Previously Vaccinated With BCG
- Status
- COMPLETED
- Phase
- PHASE1
Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons
- Status
- COMPLETED
- Phase
- NA
Safety and Immunogenicity of MVA85A, in Healthy Volunteers in Cape Town
- Status
- COMPLETED
- Phase
- PHASE1
Diagnosis of Active and Latent TB Infection With IFN-y Assays in African Children
- Status
- UNKNOWN
- Phase
- N/A
Safety and Immunogenicity of MVA85A in Volunteers Latently Infected With TB.
- Status
- COMPLETED
- Phase
- PHASE1
TMC207-TiDP13-C208: Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Participants With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB).
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Trial of a LTK63 Adjuvated Tuberculosis Nasal Subunit Vaccine (Ag85B-ESAT6)
- Status
- TERMINATED
- Phase
- PHASE1
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Received BCG Immunisation 1 Month Previously
- Status
- COMPLETED
- Phase
- PHASE1
Metronidazole for Pulmonary Tuberculosis (South Korea)
- Status
- COMPLETED
- Phase
- PHASE2